SDC1 and neoplasm: In our investigation we were not able to confirm a connection between the amount of CD8+, CD4+ and CD138+ cells, tumor recurrence or stage progression, nor the association between the amount of CD25+ cells and tumor recurrence in patients with NMIBC as described by other authors.